Allergy Thera. Share News (AGY)

Allergy Therapeutics Extends Term Of Convertible Loan

LONDON (Alliance News) - Allergy Therapeutics PLC said Thursday that it had extended the term of its GBP4.04 million convertible loan with CFR International SpA. The maturity of the loan has been extended to September 30 from April 20, all other terms of the loan are unchanged. Shares

Tuesday broker round-up UPDATE

African Barrick Gold: Deutsche Bank raises target price from 240p to 310p and keeps a hold recommendation. African Minerals: Deutsche Bank lowers target price from 399p to 382p, while its buy recommendation is kept. Allergy Therapeutics: Panmure Gordon ups target price from 16p to 25p and retains

UK BROKER RATINGS: Jefferies Raises REIT Price Targets

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
GOLDMAN RAISES INTL AIRLINES GROUP (IAG) PRICE TARGET TO 430 (420) PENCE - 'NEUTRAL'
----------
BARCLAYS CUTS PRUDEN

Allergy Therapeutics reports rise in first half profits and revenue

Allergy Therapeutics reported an 11 per cent rise in gross profit to 20.7m pounds in the first half as costs were reduced. The cost of goods fell to £6.4m in the last six months of 2013, compared to £7m, following a number of cost cutting measures. Gross revenue, excluding the German rebate and

UK MIDDAY BRIEFING: Centamin Soars As Production Beats Expectations

LONDON (Alliance News) - Metals and minerals producer Centamin is leading the FTSE 250 index Monday despite reporting a hit to pretax profit in 2013, due to a large exceptional cost, but a significant increase in revenue and production.

Centamin said pretax profit f

UK WINNERS & LOSERS: Barratt Falls On Return To FTSE 100, Downgrade

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - LOSERS

Barratt Developments, down 2.1%. Following the quarterly FTSE review on Ma

Allergy Therapeutics Profit Rises On Increased Market Share In Europe

LONDON (Alliance News) - Speciality pharmaceutical company Allergy Therapeutics PLC Monday posted a rise in pretax profit as it increased its market share in European markets and launched new products in the half-year ended December 31, 2013. Allergy Therapeutic posted a pretax profit of GB

UK Earnings, Trading Statements Calendar - Week Ahead

Read more 21 Mar 2014 16:11 UK Earnings, Trading Statements Calendar - Week Ahead Read more 21 Mar 2014 06:13 UK Earnings, Trading Statements Calendar - Week Ahead Read more 20 Mar 2014 16:02 UK Earnings, Trading Statements Calendar - Week Ahead Read more 20 Mar 2014 06:33 UK Earnings, Trading Statements Calendar - Week Ahead Read more 19 Mar 2014 16:42 UK Earnings, Trading Statements Calendar - Week Ahead Read more 19 Mar 2014 06:15 UK Earnings, Trading Statements Calendar - Week Ahead Read more 18 Mar 2014 15:54 UK Earnings, Trading Statements Calendar - Week Ahead Read more 78910111213141516 Stay Informed! With our newsletters and social media channels. Daily Market Report (Weekday Evenings)Week Ahead (Sunday Evening) Login to your account Login failed Remember MeSign In Don't have an account? Click here to register. Quickpicks are a member only feature Login to your account Login failed Remember MeSign In Don't have an account? Click here to register.